The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis
Keywords: ALS; amyotrophic lateral sclerosis; SOD1; superoxide dismutase 1; VIP; vasoactive intestinal peptide; PACAP; pituitary adenylate cyclase-activating polypeptide; SNV; stearyl-norleucine-VIP; PBS; phosphate-buffered saline; GFAP; glial fibrillary acidic pro